| Value | ₹0.02 Cr |
|---|
BSE filing, NSE: HIRECT. Summary written from the filing by ALFA Finder's alert engine.
Hind Rectifiers Ltd: key numbers
- Share price
- ₹997.60
- Market cap
- ₹3,429 Cr
- Revenue (annual)
- ₹999.1 Cr
- Net profit (annual)
- ₹45.01 Cr
- P/E (TTM)
- 82.3×Sector 43.1×
- Promoter holding
- 42.59%-1.33% QoQ
- FII holding
- 6.84%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hind Rectifiers Ltd
All →Hirect Other Announcement
Hirect Ltd submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Hirect Annual General Meeting
Hirect Limited announced Postal Ballot voting results regarding the appointment of directors and an extension of the timeline for the utilization of preferential issue funds.
Hirect Management Change
Mrs. Preeti Sharma has resigned from her position as Head Legal and Senior Management Personnel of Hirect Limited, effective September 24, 2026.
Hirect Merger & Restructuring Worth ₹4.5 Cr
Hirect Limited sold the residual part of its non-operational Dehradun plant for ₹4.5 Crore. The buyer is not part of the promoter group.
- Value
- ₹4.50 Cr
Hirect Annual General Meeting
Hirect Limited has issued a Postal Ballot notice for shareholder approval of director appointments and an extension for utilizing funds raised via preferential equity warrants.
Hirect Annual General Meeting
Hirect Limited issued a Postal Ballot Notice seeking shareholder approval for director appointments and extending the timeline for utilizing Rs. 27.36 Crore raised via warrants.
- Value
- ₹27.36 Cr
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date